Basics NeoGenomics, Inc. NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee. IPO Date: December 10, 2012 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $1.54B Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 2.25% Avg Daily Range (30 D): $0.26 | 2.43% Avg Daily Range (90 D): $0.21 | 2.52% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): 2.32M Avg Daily Volume (90 D): 2.79M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 96 Avg Trade Size (Sh.) (90 D): 120 Institutional Trades Total Inst.Trades: 3,789 Avg Inst. Trade: $2.15M Avg Inst. Trade (30 D): $1.95M Avg Inst. Trade (90 D): $2.17M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.7M Avg Closing Trade (30 D): $3.06M Avg Closing Trade (90 D): $2.45M Avg Closing Volume: 149.65K     News Jun 25, 2025 @ 6:51 AM 3 Hot Trades for Insiders, But Are They Good Buys ... Source: Marketbeat.Com May 6, 2025 @ 4:20 PM It's Not Too Late to Jump on These Under-the-Radar... Source: Marketbeat.Com Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 187.8M $ 181.33M $ 168.04M Gross Profit $ 80.45M $ 77.26M $ 73.25M Net Income / Loss $ -27.13M $ -45.09M $ -25.92M Operating Income / Loss $ -27.01M $ -47.63M $ -27.83M Cost of Revenue $ 107.35M $ 104.07M $ 94.79M Net Cash Flow $ 9.37M $ -191.42M $ -20.82M PE Ratio     Splits Apr 16, 2003:   1:100 Nov 17, 2000:   4:1